Cirrus Expands To Singapore, Advances Novel Eye Therapies
KUALA LUMPUR, March 4 (Bernama) -- Cirrus Therapeutics, a global ocular immunology company, announced several business and pipeline updates to support its strategy of advancing first-in-class and best-in-class therapies for chronic blinding diseases.